Outcomes Published in Canadian Journal of
Diabetes Suggest Compelling Path Forward Across All Canadian
Provinces.
TORONTO, Feb. 7, 2023
/CNW/ - Newtopia Inc. ("Newtopia" or the
"Company") (TSXV: NEWU) (OTCQB: NEWUF), a tech-enabled
whole health platform creating sustainable habits that prevent,
slow and reverse chronic disease, today announced the success of a
partnership with Medtronic Canada and the collaboration with
Eastern Health to proactively prevent, slow and reverse Type 2
diabetes burden in Newfoundland
and Labrador through an
innovative, value-based approach.
The pilot program was based on Eastern Health's recognition of
the need to improve health outcomes for approximately 30% of the
population - nearly 175,000 Newfoundland and Labrador residents - who live with, or are at
risk of developing, diabetes.1 Under a contract designed
specifically around value-based payment triggers, participants in
the trial received 1:1 dedicated health coaching delivered
virtually using Newtopia's personalized lifestyle and habit change
platform.
Weight loss trends among participants showed a decrease from a
baseline of 3.5% of body weight at 6 months and 6.4% at 10 months.
Among participants with two or more A1c test results, A1c declined
by an average of 0.5, and 1.1 for those with an initial A1c of 9.0
or above.2 Outcomes were accompanied by impressive
engagement levels of 81% among participants, further highlighting
the effectiveness of Newtopia's humans-helping-humans approach
amplified by technology. Qualitative feedback from participants
included, "this program changed my life – my doctor has even
suggested that we may halt medication because of my improved A1c
levels."
The success of the pilot program led to recognition by the
Canadian Diabetes Association with a presentation of an outcomes
analysis at the 2022 Diabetes Canada/CSEM Professional Conference,
as well as the publication of results in the Canadian Journal of
Diabetes.
Global experience demonstrates that the transition of healthcare
systems towards better cost-of-care value in relation to improved
health outcomes and experiences requires the collaboration of the
health industry as a whole, as well as initiatives that demonstrate
the power of value-based partnerships between public and private
sectors. Given growing awareness in Canada of the need to intervene in social
determinants of health, as well as the balance of community-based
and hospital-based services, Newtopia's innovations with
engagement- and outcomes-based economics make establishing
value-based contracting simple and intuitive with the goals of
increased patient participation, health and lifestyle improvements
with clinically significant outcomes, and cost
reductions.
"As an original executive sponsor of the pilot, we are
delighted to see these results. We entered a strategic
partnership with Medtronic and Newtopia to implement a pilot
project to procure an outcome for diabetes management. The program
deployed a personalized behavior change and lifestyle modification
solution with virtual coaching to improve the quality of life for
our residents and proactively reduce rising costs," said
Debbie Walsh, Vice President and
Chief Nursing Officer at Eastern Health. "As a result of the great
success, Eastern Health is actively developing a plan to scale the
program in primary health."
"Medtronic is thrilled with the impact of this pilot project and
having Newtopia as a partner at the table, as an extension of our
Innovation Partnership with Eastern Health, to help address the
pressing issue of relatively high rates of pre-diabetes in
Newfoundland and Labrador," said Jessica Rudd, National Director of New
Partnerships and Solutions at Medtronic. "The pilot program's
results strongly support the value of a thoughtfully integrated
digital solution to engage patients in their health and wellness,
drive improved patient outcomes, and benefit the health system
overall."
"As a Canadian-founded health tech leader, we value our
partnership with Medtronic Canada and our joint initiative to
effectively address the country-wide growing problem of Type-2
diabetes," said Jeff Ruby, Founder
and CEO of Newtopia. "In addition to the compelling engagement and
clinical outcomes from the pilot, we are pleased to see Eastern
Health lead innovation in both slowing and reversing type-2
diabetes and value-based contracting. We are confident that
alongside Medtronic, we will continue to deliver better diabetes
health outcomes across Canadian Provinces."
The pilot program results are also consistent with Newtopia's
recent receipt of the highest Full-Plus recognition from the
Centers for Disease Control and Prevention for delivering a
proven, highly effective alternative diabetes prevention program.
1Estimated
Prevalence and Cost of Diabetes in Newfoundland and Labrador,
Canadian Diabetes Association, 2023.
|
|
2Setliff,
A., Fry, F., Ryan, A., Dodo, L., Vani, N., Oza-Sturgeon, H., ...
& Fensterheim, L. (2022). Addressing Diabetes Burden With
Personalized Lifestyle and Habit Change Coaching. Canadian Journal
of Diabetes, 46(7), S3.
|
About Newtopia
Newtopia is a personalized whole health platform helping people
create positive lifelong habits that prevent, slow, or reverse
chronic disease while reducing healthcare costs. The
platform leverages
genetic, social and behavioral insights
to create individualized prevention programs
with a focus on metabolic disease, diabetes, mental health
challenges, hypertension, weight management and musculoskeletal
disorders. With a person-centered approach that combines
virtual care, digital tools, connected devices and actionable data
science, Newtopia delivers sustainable clinical and financial
outcomes. Newtopia serves
some of the largest nationwide employers and health
plans and is currently listed in Canada on the Toronto
Stock Exchange (TSXV: NEWU) and is quoted in the US on
the OTCQB® Venture Market (OTCQB: NEWUF). To
learn more, visit newtopia.com, LinkedIn or Twitter.
About Medtronic Canada
ULC
Bold thinking. Bolder actions. We are Medtronic. Proud to serve
Canadian healthcare for over 50 years, Medtronic Canada ULC is
headquartered in Brampton, Ontario, and is a subsidiary of Medtronic plc.
We are the leading global healthcare technology company that boldly
attacks the most challenging health problems facing humanity by
searching out and finding solutions. Our Mission — to alleviate
pain, restore health, and extend life — unites a global team of
90,000+ passionate people. Our technologies and therapies address
70 health conditions and include cardiac devices, surgical
robotics, insulin pumps, surgical tools, patient monitoring
systems, and more. Powered by our diverse knowledge, insatiable
curiosity, and desire to help all those who need it, we deliver
innovative technologies that transform the lives of two people
every second, every hour, every day. Expect more from us as we
empower insight-driven care, experiences that put people first, and
better outcomes for our world. In everything we do, we are
engineering the extraordinary. For more on Medtronic Canada,
visit www.Medtronic.ca, Twitter and LinkedIn.
About Eastern
Health
Eastern Health is the largest, integrated health authority in
Newfoundland and Labrador employing approximately 13,000
dedicated employees, over 700 medical staff, and is supported by
hundreds of volunteers, including members of numerous auxiliaries
and fundraising foundations. With an annual budget of approximately
$1.7 billion, the authority offers
the full continuum of health and community services including
public health, long-term care, community services, hospital care
and unique provincial programs and services. Serving a population
of over 300,000, Eastern Health's geographic boundaries extend west
from St. John's to Port Blandford including all communities on
the Avalon, Burin and Bonavista Peninsulas.
Forward Looking Statements
This news release contains forward-looking information and
forward-looking statements, within the meaning of applicable
Canadian securities legislation, and forward looking statements,
within the meaning of applicable United
States securities legislation (collectively,
"forward-looking statements"), which reflects management's
expectations regarding Newtopia's future
growth, results from operations (including, without limitation,
future production and capital expenditures), performance (both
operational and financial) and business prospects and
opportunities. Wherever possible, words such as "predicts",
"projects", "targets", "plans", "expects", "does not expect",
"budget", "scheduled", "estimates", "forecasts", "anticipate" or
"does not anticipate", "believe", "intend" and similar
expressions or statements that certain actions, events
or results "may", "could", "would", "might" or "will" be
taken, occur or be achieved, or the negative or grammatical
variation thereof or other variations thereof, or comparable
terminology have been used to identify
forward-looking statements. All statements other than statements of historical fact may be forward- looking
information. Such statements reflect Newtopia's current views and
intentions with respect to future events, based on information
available to Newtopia, and are subject to certain risks,
uncertainties, and assumptions. Material factors or
assumptions were applied in providing forward-looking information.
While forward-looking statements are based on data,
assumptions and analyses that Newtopia believes are reasonable
under the circumstances, whether actual results, performance or
developments will meet Newtopia's expectations and predictions
depends on a number of risks and uncertainties that could
cause the actual results,
performance and financial condition of Newtopia
to differ materially from its expectations. Forward-looking
statements are not a guarantee and are based on a number of
estimates and assumptions management believes to be relevant and
reasonable, whether actual results, performance or developments
will meet Newtopia's expectations and predictions depends on
a number of risks and uncertainties that could cause the
actual results, performance and financial condition of
Newtopia to differ materially from its expectations. Certain of the
"risk factors" that could cause actual results
to differ materially from Newtopia's
forward-looking statements in this press release include, without
limitation: the termination of contracts by clients, risks related
to COVID-19 including various recommendations, orders and measures
of governmental authorities to try to limit the pandemic, including
travel restrictions, border closures, non-essential business
closures, quarantines, self-isolations, shelters- in-place and
social distancing, disruptions to markets, economic activity,
financing, supply chains and sales channels, and a deterioration of
general economic conditions including a possible national or global
recession; and other general economic, market and business
conditions and factors, including the risk factors discussed or
referred to in Newtopia's disclosure documents, filed with the
securities regulatory authorities in certain provinces of
Canada and available at
www.sedar.com including Newtopia's final
long form prospectus
dated March 30, 2020.
Should any factor affect Newtopia's in an unexpected manner, or
should assumptions underlying the forward- looking information
prove incorrect, the actual results or events may differ materially
from the results or events predicted. Any such forward-looking
information is expressly qualified in its entirety by this
cautionary statement. Moreover,
Newtopia does not assume responsibility for the accuracy
or completeness of such forward-looking information. The
forward-looking information included in this press release is
made as of the date of this press release, and Newtopia undertakes
no obligation to publicly update or revise
any forward-looking information, other than as
required by applicable law.
Neither the TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/successful-newtopia-and-medtronic-lifestyle-intervention-pilot-to-address-prevalence-of-type-2-diabetes-exceeds-expectations-in-newfoundland-and-labrador-301739974.html
SOURCE Newtopia Inc.